Zurcher Kantonalbank Zurich Cantonalbank Has $68.71 Million Stock Position in Encompass Health Co. (NYSE:EHC)

Zurcher Kantonalbank Zurich Cantonalbank grew its position in Encompass Health Co. (NYSE:EHC - Free Report) by 10.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 744,046 shares of the company's stock after purchasing an additional 70,418 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank owned approximately 0.74% of Encompass Health worth $68,713,000 at the end of the most recent quarter.

A number of other hedge funds have also modified their holdings of EHC. MassMutual Private Wealth & Trust FSB grew its stake in shares of Encompass Health by 87.8% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company's stock worth $27,000 after acquiring an additional 137 shares in the last quarter. Avior Wealth Management LLC bought a new position in Encompass Health in the third quarter valued at $40,000. Tompkins Financial Corp acquired a new stake in Encompass Health in the 4th quarter valued at $46,000. V Square Quantitative Management LLC lifted its position in Encompass Health by 43.8% during the 4th quarter. V Square Quantitative Management LLC now owns 581 shares of the company's stock worth $54,000 after buying an additional 177 shares in the last quarter. Finally, Morse Asset Management Inc acquired a new position in shares of Encompass Health during the 3rd quarter worth about $68,000. 97.25% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on the company. Barclays upped their target price on Encompass Health from $116.00 to $118.00 and gave the stock an "overweight" rating in a report on Friday, February 7th. William Blair reissued an "outperform" rating on shares of Encompass Health in a research report on Friday, February 7th. StockNews.com upgraded Encompass Health from a "hold" rating to a "buy" rating in a research note on Saturday, February 15th. KeyCorp increased their price target on Encompass Health from $117.00 to $120.00 and gave the company an "overweight" rating in a research note on Monday, February 10th. Finally, Royal Bank of Canada reaffirmed an "outperform" rating and set a $110.00 price objective on shares of Encompass Health in a research report on Tuesday, February 11th. Ten research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat.com, Encompass Health has an average rating of "Buy" and a consensus target price of $107.67.

Remove Ads

Encompass Health Stock Performance

NYSE:EHC traded down $0.71 during mid-day trading on Thursday, reaching $93.57. 836,587 shares of the company's stock were exchanged, compared to its average volume of 637,145. Encompass Health Co. has a one year low of $74.27 and a one year high of $104.55. The company has a debt-to-equity ratio of 0.84, a quick ratio of 1.04 and a current ratio of 1.05. The business's fifty day simple moving average is $97.22 and its two-hundred day simple moving average is $96.88. The firm has a market capitalization of $9.42 billion, a PE ratio of 20.98, a price-to-earnings-growth ratio of 2.31 and a beta of 0.92.

Encompass Health (NYSE:EHC - Get Free Report) last announced its earnings results on Thursday, February 6th. The company reported $1.17 EPS for the quarter, topping the consensus estimate of $1.05 by $0.12. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. Analysts anticipate that Encompass Health Co. will post 4.8 earnings per share for the current fiscal year.

Encompass Health Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, April 15th. Stockholders of record on Tuesday, April 1st will be given a dividend of $0.17 per share. The ex-dividend date of this dividend is Tuesday, April 1st. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.73%. Encompass Health's payout ratio is 15.25%.

Insider Transactions at Encompass Health

In related news, CAO Andrew L. Price sold 5,042 shares of the company's stock in a transaction dated Thursday, February 13th. The shares were sold at an average price of $98.29, for a total transaction of $495,578.18. Following the completion of the sale, the chief accounting officer now owns 69,164 shares of the company's stock, valued at $6,798,129.56. This represents a 6.79 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. 2.10% of the stock is currently owned by insiders.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.